Showing results (261-270 of 19,274) with videos related to

Sort By:
Pageof 1,928
Transplantation|April 1, 1998
Preemptive treatment for the prevention of cytomegalovirus disease: in lung and heart transplant recipientsJ J Egan, J Lomax, L Barber, et al.
Transplantation|August 15, 1997
Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agentsH Reichenspurner, V Soni, M Nitschke, et al.
Transplantation|August 15, 1997
Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factorA Pascher, C Poehlein, M Storck, et al.
Transplantation|August 15, 1997
Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the ratI Lautenschlager, A Soots, L Krogerus, et al.
Transplantation|August 15, 1997
Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcomeT Gayowski, N Singh, I R Marino, et al.
Transplantation|August 15, 1997
Quantitation of the changes in splenic architecture during the rejection of cardiac allografts or xenograftsJ Shen, J Short, L Blinder, et al.
Transplantation|August 15, 1997
Incidence of adenomatous colorectal polyps in cardiac transplant recipientsJ M Rodriguez-Larrain, J J Ziebert, A G Kfoury, et al.
Transplantation|August 15, 1997
Ex vivo adenovirus-mediated gene delivery leads to long-term expression in pancreatic islet transplantsD A Muruve, R C Manfro, T B Strom, et al.
Transplantation|March 1, 1993
Implications of de novo ELAM-1 and VCAM-1 expression in human cardiac allograft rejectionC Ferran, M Peuchmaur, M Desruennes, et al.
Transplantation|March 1, 1993
Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejectionC Brockmeyer, M Ulbrecht, D J Schendel, et al.
Pageof 1,928